Literature DB >> 7950572

Use of beta 2 agonists in asthma: much ado about nothing? Still cause for concern.

A E Tattersfield1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7950572      PMCID： PMC2540987          DOI： 10.1136/bmj.309.6957.794

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.

Authors:  A S Vathenen; A J Knox; B G Higgins; J R Britton; A E Tattersfield
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

2.  Asthma control during and after cessation of regular beta 2-agonist treatment.

Authors:  I Wahedna; C S Wong; A F Wisniewski; I D Pavord; A E Tattersfield
Journal:  Am Rev Respir Dis       Date:  1993-09

3.  Regular inhaled salbutamol and airway responsiveness to allergen.

Authors:  D W Cockcroft; C P McParland; S A Britto; V A Swystun; B C Rutherford
Journal:  Lancet       Date:  1993-10-02       Impact factor: 79.321

4.  Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.

Authors: 
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

5.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Authors:  W Castle; R Fuller; J Hall; J Palmer
Journal:  BMJ       Date:  1993-04-17

6.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

Authors:  N Pearce; J Grainger; M Atkinson; J Crane; C Burgess; C Culling; H Windom; R Beasley
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

7.  The use of beta-agonists and the risk of death and near death from asthma.

Authors:  W O Spitzer; S Suissa; P Ernst; R I Horwitz; B Habbick; D Cockcroft; J F Boivin; M McNutt; A S Buist; A S Rebuck
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

8.  Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.

Authors:  C S Wong; I D Pavord; J Williams; J R Britton; A E Tattersfield
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321
  8 in total
  4 in total

1.  Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.

Authors:  R M Martin; N R Dunn; S N Freemantle; R D Mann
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 2.  Clinical management of asthma in the 1990s. Current therapy and new directions.

Authors:  P Jain; J A Golish
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 3.  Asthma and the beta agonist debate.

Authors:  J Crane; N Pearce; C Burgess; R Beasley
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

4.  Treating asthma. Beta agonists are widely used.

Authors:  A Jones
Journal:  BMJ       Date:  1995-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.